Showing results (621-630 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|January 15, 2010
Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environmentsKarina M Soares, Nicole Blackmon, Tong Ying Shun, et al.
Assay and Drug Development Technologies|January 29, 2010
ADP-Glo: A Bioluminescent and homogeneous ADP monitoring assay for kinasesHicham Zegzouti, Marina Zdanovskaia, Kevin Hsiao, et al.
Assay and Drug Development Technologies|October 17, 2018
Alternative Pharmaceutical Formulation for Oral Administration of RifampicinPriscila Cristina Bartolomeu Halicki, Gabriela Hädrich, Raphael Boschero, et al.
Assay and Drug Development Technologies|April 9, 2019
High-Throughput Zika Viral Titer Assay for Rapid Screening of Antiviral DrugsEmily M Lee, Steven A Titus, Miao Xu, et al.
Assay and Drug Development Technologies|June 6, 2018
Engineered EF-Tu and tRNA-Based FRET Screening Assay to Find Inhibitors of Protein Synthesis in BacteriaRachana Bhatt, Maxim Chudaev, Wlodek Mandecki, et al.
Assay and Drug Development Technologies|May 17, 2019
The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived NeuronsElizabeth R Sharlow, Mehmet Murat Koseoglu, George S Bloom, et al.
Assay and Drug Development Technologies|May 26, 2022
Formulation and Characterization of Raloxifene Nanostructured Lipid Carriers for Permeability and Uptake Enhancement ApplicationsAnju Sharma, Jarriaun Streets, Priyanka Bhatt, et al.
Assay and Drug Development Technologies|January 19, 2018
Research in Rare Disease: From Genomics to ProteomicsJessica Lacoste
Assay and Drug Development Technologies|February 3, 2018
Integration of Antibody Array Technology into Drug Discovery and DevelopmentWei Huang, Kelly Whittaker, Huihua Zhang, et al.
Assay and Drug Development Technologies|February 25, 2015
Development of a phenotypic high-content assay to identify pharmacoperone drugs for the treatment of primary hyperoxaluria type 1 by high-throughput screeningFranck Madoux, Jo Ann Janovick, David Smithson, et al.
Pageof 100